• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践中的强直性脊柱炎功能和活动指数

Ankylosing spondylitis functional and activity indices in clinical practice.

作者信息

Popescu C, Trandafir M, Bădică Am, Morar F, Predeţeanu D

机构信息

"Sfânta Maria" Clinical Hospital, Bucharest ; "Carol Davila" University of Medicine and Pharmacy, Department of Internal Medicine and Rheumatology, Bucharest.

"Sfânta Maria" Clinical Hospital, Bucharest.

出版信息

J Med Life. 2014 Mar 15;7(1):78-83. Epub 2014 Mar 25.

PMID:24653763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3956102/
Abstract

BACKGROUND

Clinicians have at hand several indices to evaluate disease activity and functionality in ankylosing spondylitis (AS), in order to evaluate the prognostic and the treatment of AS patients.

OBJECTIVES

to examine the relationship between functional and activity scores in AS; to note whether disease activity is associated with any clinical or laboratory variables.

METHODS

the study included AS patients, classified according to the revised New York criteria; data recorded: demographics, disease duration, type of articular involvement, HLA B27 presence, history of uveitis, calculation of BASFI, BASDAI and ASDASCRP, quantification of inflammation markers.

RESULTS

50 AS patients; ASDASCRP correlated significantly (p < 0.001) with BASFI (r = 811), BASDAI (r = 0.810) and with erythrocyte sedimentation rate (ESR; r = 0.505); HLA B27 positive patients had a median BASDAI 5 times higher than HLA B27 negative patients (p = 0.033); compared with patients with strictly axial disease form, patients with axial and peripheral disease had a median ESR 3 times higher (p = 0.042) and a median BASDAI 2 times higher (p = 0.050).

CONCLUSIONS

functional and activity AS indices are strongly correlated in assessing disease severity; inflammation and HLA B27 can predict the high value of these indices; axial and peripheral disease pattern is associated with higher disease activity.

摘要

背景

临床医生手头有多种指标可用于评估强直性脊柱炎(AS)的疾病活动度和功能,以便对AS患者进行预后评估和治疗。

目的

研究AS患者功能评分与活动度评分之间的关系;观察疾病活动度是否与任何临床或实验室变量相关。

方法

本研究纳入了根据修订的纽约标准分类的AS患者;记录的数据包括:人口统计学信息、病程、关节受累类型、HLA B27状态、葡萄膜炎病史、计算BASFI、BASDAI和ASDASCRP,以及炎症标志物定量。

结果

50例AS患者;ASDASCRP与BASFI(r = 0.811)、BASDAI(r = 0.810)以及红细胞沉降率(ESR;r = 0.505)显著相关(p < 0.001);HLA B27阳性患者的BASDAI中位数比HLA B27阴性患者高5倍(p = 0.033);与单纯轴向疾病形式的患者相比,轴向和外周疾病患者的ESR中位数高3倍(p = 0.042),BASDAI中位数高2倍(p = 0.050)。

结论

在评估疾病严重程度时,AS的功能和活动度指标密切相关;炎症和HLA B27可预测这些指标的高值;轴向和外周疾病模式与更高的疾病活动度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/3324a102c875/JMedLife-07-78-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/4b909d8a774c/JMedLife-07-78-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/49024dd508cc/JMedLife-07-78-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/621dda5525ec/JMedLife-07-78-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/365a13b1592d/JMedLife-07-78-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/81b29ee7e8df/JMedLife-07-78-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/3324a102c875/JMedLife-07-78-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/4b909d8a774c/JMedLife-07-78-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/49024dd508cc/JMedLife-07-78-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/621dda5525ec/JMedLife-07-78-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/365a13b1592d/JMedLife-07-78-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/81b29ee7e8df/JMedLife-07-78-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c3/3956102/3324a102c875/JMedLife-07-78-g006.jpg

相似文献

1
Ankylosing spondylitis functional and activity indices in clinical practice.临床实践中的强直性脊柱炎功能和活动指数
J Med Life. 2014 Mar 15;7(1):78-83. Epub 2014 Mar 25.
2
Profile of HLA-B27-positive enthesitis/spondylitis-related arthritis in Senegal, West Africa.塞内加尔(西非) HLA-B27 阳性附着点炎/脊柱炎相关关节炎患者的特征。
Pediatr Rheumatol Online J. 2024 Feb 29;22(1):31. doi: 10.1186/s12969-024-00969-1.
3
The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.Bath 强直性脊柱炎疾病活动指数、强直性脊柱炎疾病活动评分、C 反应蛋白和红细胞沉降率在脊柱关节炎相关轴性关节炎中的鉴别价值。
J Clin Rheumatol. 2017 Aug;23(5):267-272. doi: 10.1097/RHU.0000000000000522.
4
[Comparison of clinical manifestations according to HLA-B(27) genotype in ankylosing spondylitis patients: real-world evidence from smart management system for spondyloarthritis].强直性脊柱炎患者中根据HLA-B(27)基因型的临床表现比较:来自脊柱关节炎智能管理系统的真实世界证据
Zhonghua Nei Ke Za Zhi. 2018 Mar 1;57(3):179-184. doi: 10.3760/cma.j.issn.0578-1426.2018.03.006.
5
Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.HLA-B27 对强直性脊柱炎表型的影响:来自 REGISPONSER 数据库的结果。
Arthritis Res Ther. 2018 Oct 3;20(1):221. doi: 10.1186/s13075-018-1724-7.
6
Semaphorin 3A in Ankylosing Spondylitis.强直性脊柱炎中的 Sema3A。
J Microbiol Immunol Infect. 2019 Feb;52(1):151-157. doi: 10.1016/j.jmii.2017.07.001. Epub 2017 Jul 14.
7
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.一线肿瘤坏死因子抑制剂在影像学和非影像学轴向脊柱关节炎中的不同药物生存:一项多中心回顾性调查。
Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.
8
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.强直性脊柱炎疾病活动度评分简化版(SASDAS)用于评估中轴型脊柱关节炎疾病活动度的结构效度和反应性。
Health Qual Life Outcomes. 2014 Aug 22;12:129. doi: 10.1186/s12955-014-0129-9.
9
A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.强直性脊柱炎患者的简化版强直性脊柱炎疾病活动评分(ASDAS)。
Clin Rheumatol. 2012 Nov;31(11):1599-603. doi: 10.1007/s10067-012-2056-7. Epub 2012 Aug 16.
10
Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.强直性脊柱炎疾病活动评分(ASDAS)在非放射学轴性脊柱关节炎和强直性脊柱炎患者中的判别效度:一项队列研究
Rheumatol Int. 2015 Jun;35(6):981-9. doi: 10.1007/s00296-014-3168-y. Epub 2014 Nov 4.

引用本文的文献

1
Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?血清粒细胞巨噬细胞集落刺激因子和CCL17水平能否作为脊柱关节炎疾病活动的标志物?
Arch Rheumatol. 2024 Mar 20;39(3):368-374. doi: 10.46497/ArchRheumatol.2024.10360. eCollection 2024 Sep.
2
Correlations among quality of life, spinal mobility, and disease activity in early-treated axial spondyloarthritis: a single-center cross-sectional study.早期治疗的中轴型脊柱关节炎患者生活质量、脊柱活动度与疾病活动度之间的相关性:一项单中心横断面研究
BMC Rheumatol. 2024 Oct 16;8(1):54. doi: 10.1186/s41927-024-00426-2.
3

本文引用的文献

1
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.强直性脊柱炎国际评估协会分类标准:外周型脊柱关节炎和一般型脊柱关节炎。
Ann Rheum Dis. 2011 Jan;70(1):25-31. doi: 10.1136/ard.2010.133645. Epub 2010 Nov 24.
2
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.强直性脊柱炎疾病活动评分 (ASDAS):确定疾病活动状态和改善评分的临界值。
Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594. Epub 2010 Nov 10.
3
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
Efficacy of myofascial induction compared with its simulation on joint amplitude in people with axial spondylarthritis: Protocol of a randomized controlled clinical trial.
肌筋膜激痛点推拿与肌筋膜模拟推拿治疗强直性脊柱炎患者关节活动度的随机对照临床试验方案
PLoS One. 2023 Oct 5;18(10):e0286885. doi: 10.1371/journal.pone.0286885. eCollection 2023.
4
Structural Lesion Progression of the Sacroiliac Joint and Clinical Features in axSpA During TNFi Reduction: A Retrospective Cohort Study.肿瘤坏死因子抑制剂减量期间强直性脊柱炎患者骶髂关节结构病变进展及临床特征:一项回顾性队列研究
Front Med (Lausanne). 2021 Dec 7;8:781088. doi: 10.3389/fmed.2021.781088. eCollection 2021.
5
Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.巴西风湿病学会 2020 年银屑病关节炎治疗指南。
Adv Rheumatol. 2021 Nov 24;61(1):69. doi: 10.1186/s42358-021-00219-y.
6
HLA-B27 is associated with reduced disease activity in axial spondyloarthritis.人类白细胞抗原B27(HLA - B27)与轴性脊柱关节炎疾病活动度降低相关。
Sci Rep. 2021 Jun 10;11(1):12331. doi: 10.1038/s41598-021-91829-5.
7
Does HLA-B27 Status Influence Ankylosing Spondylitis Phenotype?HLA - B27状态是否会影响强直性脊柱炎的表型?
Clin Med Insights Arthritis Musculoskelet Disord. 2018 Jan 8;11:1179544117751627. doi: 10.1177/1179544117751627. eCollection 2018.
8
Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).强直性脊柱炎疾病活动度评分简化版(SASDAS)的性能特征。
Clin Rheumatol. 2016 Jul;35(7):1753-8. doi: 10.1007/s10067-015-3147-z. Epub 2015 Dec 16.
国际脊柱关节炎协会轴性脊柱关节炎分类标准的制定(第二部分):验证与最终选定
Ann Rheum Dis. 2009 Jun;68(6):777-83. doi: 10.1136/ard.2009.108233. Epub 2009 Mar 17.
4
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.强直性脊柱炎患者中一种获得脊柱关节炎国际学会(ASAS)认可的疾病活动评分(ASDAS)的开发。
Ann Rheum Dis. 2009 Jan;68(1):18-24. doi: 10.1136/ard.2008.094870. Epub 2008 Jul 14.
5
Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies.强直性脊柱炎、HLA - B27阳性与生物治疗需求
Joint Bone Spine. 2007 Mar;74(2):140-3. doi: 10.1016/j.jbspin.2006.11.003. Epub 2007 Feb 7.
6
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.强直性脊柱炎的严重程度是否存在性别差异?来自腰大肌队列研究的结果。
Ann Rheum Dis. 2007 May;66(5):633-8. doi: 10.1136/ard.2006.060293. Epub 2006 Nov 24.
7
Ankylosing spondylitis--cardiac manifestations.强直性脊柱炎——心脏表现
Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S11-5.
8
Functional disability predicts total costs in patients with ankylosing spondylitis.功能残疾可预测强直性脊柱炎患者的总费用。
Arthritis Rheum. 2002 Jan;46(1):223-31. doi: 10.1002/1529-0131(200201)46:1<223::AID-ART498>3.0.CO;2-#.
9
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients.强直性脊柱炎患者的就业、工作残疾及误工天数:一项针对荷兰患者的横断面研究
Ann Rheum Dis. 2001 Apr;60(4):353-8. doi: 10.1136/ard.60.4.353.
10
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.一种定义强直性脊柱炎疾病状态的新方法:巴斯强直性脊柱炎疾病活动指数。
J Rheumatol. 1994 Dec;21(12):2286-91.